Key facts
- IXI’s last known valuation is $62.2M (Aug 2024).
- It has raised $76.6M; the latest was Early Stage VC ($36.6M) in Apr 2025.
- Notable investors include European Innovation Council, Tiny Supercomputer Investment Company, Firstminute Capital, Tesi, Heartcore Capital — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for IXI
- ·The full record, as it builds
Funding rounds
No funding rounds for IXI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IXI
Developer of optical eyeglasses technology designed to provide good vision. The company specializes in lenses that provide a wide and clear field of view for near and intermediate distances, addressing the limitations of today's progressive lenses, providing customers with a farsighted eyeglass prescription to read and work with optimal vision.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Espoo, Finland
- Founded
- 2021
- Employees
- 75
- Website
- ixieyewear.com/
- Ownership
- Privately Held (backing)
IXI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IXI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IXI in its N-PORT filings yet. We sweep new filings monthly.